Record Display for the EPA National Library Catalog

RECORD NUMBER: 398 OF 786

Main Title Health and environmental effects profile for propazine.
CORP Author United States. Environmental Protection Agency. Environmental Criteria and Assessment Office.; Syracuse Research Corporation.
Publisher U.S. Environmental Protection Agency,
Year Published 1984
Report Number EPA 600-X-84-206
Stock Number PB88-161617
OCLC Number 17668149
Subjects Hazardous wastes--Environmental aspects ; Environmental health
Additional Subjects Hazardous wastes--Environmental aspects ; Environmental health ; Pesticides ; Toxicology ; Hazardous materials ; Assessments ; Carcinogens ; Health risks ; Toxic substances ; Water pollution ; Propazine ; CAS 139-40-2
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
EJBD ARCHIVE EPA 600-X-84-206 Headquarters Library/Washington,DC 01/31/2024
EJBD  EPA 600-X-84-206 Headquarters Library/Washington,DC 11/19/2013
EKBD  EPA/600/X-84/206 Research Triangle Park Library/RTP, NC 01/01/1988
ELBD ARCHIVE EPA 600-X-84-206 Received from HQ AWBERC Library/Cincinnati,OH 10/04/2023
ELBD RPS EPA 600-X-84-206 repository copy AWBERC Library/Cincinnati,OH 03/23/2015
NTIS  PB88-161617 Some EPA libraries have a fiche copy filed under the call number shown. 07/26/2022
Collation vii, 23 leaves
Abstract
The Health and Environmental Effects Profile for propazine was prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office of Solid Waste to support listings of hazardous constituents of a wide range of waste streams under Section 3001 of the Resource Conservation and Recovery Act (RCRA). Both published literature and information obtained from Agency program office files were evaluated as they pertained to potential human health, aquatic life and environmental effects of hazardous waste constituents. Quantitative estimates have been presented provided sufficient data are available. Propazine has been evaluated as a carcinogen. The human carcinogen potency factor (q(l)*) for propazine is .078 (mg/kg bw/day)-1 for oral exposure.
Notes
"Prepared by Syracuse Research Corporation under EPA contract no. 68-03-3228." "Environmental Criteria and Assessment Office, Office of Health and Environmental Assessment, Office of Research and Development." "January 1984." "EPA 600-X-84-206." Includes bibliographical references.